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Background: To systematically assess the literature published after 1997 describing the effectiveness of nutritional interventions in Cystic Fibrosis
patients.
Methods: An online search in PUBMED, EMBASE and COCHRANE databases was conducted. Original studies with 4 patients or more,
describing a nutritional intervention and giving at least weight as an outcome parameter were included.
Results: The inclusion criteria were met by 17 articles, focusing on respectively behavioural interventions (n=6), oral supplementation (n=4) or
enteral tube feeding (n=7). This latter intervention was universally successful to induce weight gain. One behavioural study and 2 oral
supplementation studies also reported signiﬁcant weight gain.
Conclusion: Enteral tube feeding is effective to improve nutritional status, while the described effects of behavioural intervention and oral
supplementation are not consistent at present.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Diet; Body size; Gastrostomy; Cystic Fibrosis; Nutrition assessment
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Cystic Fibrosis (CF) is the most common lethal genetic
disorder in Caucasians, affecting 1 in 4750 live births [1]. It is
characterized by a gradual decline in pulmonary function,
intestinal malabsorption and often an impaired nutritional status.
Lung disease and nutritional status are tightly intertwined [2]
and both are strong predictors of morbidity and mortality in
patients with CF [1,3,4]. Malnutrition, due to a negative energy
balance, is a common problem caused by a combination of
faecal fat losses and increased energy requirements due to
chronic infections [5]. Therefore, dietary guidelines prescribe
that patients with CF should attain up to 200% of the recom-
mended daily caloric intake [6,7]. However, this can be difficult
to achieve because patients may have reduced appetite,
infection-related anorexia, gastro-oesophageal reflux or abdom-
inal pain. In this respect nutritional interventions can be helpful
to increase caloric intake. In 1997, Jelalian et al. described in a
meta-analysis that all nutritional interventions aimed at gaining
weight were successful, including behavioural modifications,
oral supplementation, enteral tube feeding as well as parenteral
nutrition [8]. As CF treatment, and thus the nutritional status of
patients has changed during the last 15 years [9,10], effective-
ness of nutritional interventions might have changed too. There-
fore, we have conducted a systematic review of the literature
published after 1997, describing the current effectiveness of
interventions aimed at enhancing nutritional status in patients
with CF.2. Methods
An online search in PUBMED, EMBASE and COCHRANE
Central Register of Controlled Trials was carried out for all
available articles published from the 1st of January 1997 up to
April 30th, 2012. The search query was: ‘Cystic Fibrosis’
[MESH] AND ‘Nutritional Status’ [MESH], ‘Cystic Fibrosis’
[MESH] AND ‘Diet’ [MESH], ‘Cystic Fibrosis’ [MESH] AND
(‘Body Size’ [MESH] OR ‘Body Weight’ [MESH]), ‘Cystic
Fibrosis’ [MESH] AND ‘Gastrostomy’ [MESH] OR ‘Enteral
Nutrition’ [MESH]. With this latter search term also studies
using (nasogastric) tube feeding were identified. The reference
lists of eligible articles and review articles were examined for
additional studies. Excluded were articles concerning animals,non-English or non-Dutch articles, editorials, reviews, meta-
analyses, articles with no abstract available and articles with
a minimal sample size of three subjects or less. The search
yielded 361 articles which were screened on title and abstract,
and considered suitable if a nutritional intervention, with the
aim to improve weight in CF patients, was described. Studies
conducted in subgroups only, such as patients with CF related
diabetes, were excluded. This resulted in 119 publications that
were potentially eligible, which were subsequently screened on
full text. To pass this final screening it was necessary that the
clinical outcome included a weight variable, either absolute
weight, z-score weight, weight-percentile, weight percentage,
weight-for-height or body-mass-index (BMI), as a result of
the treatment applied. Finally 17 articles were appropriate and
included in this review. These studies described interventions
involving behavioural modification aimed at increasing caloric
intake, prescription of oral supplements or enteral tube feeding
through a gastrostomy.
The following data were extracted: the name of the first
author, country and year of publication, study design, the
intervention offered for nutritional rehabilitation, duration of the
intervention, size and, if available, gender and age distribution
of the study population, initial weight, caloric intake, the
duration of follow-up and, if described, pulmonary function
assessed as forced expiratory volume in 1 s, expressed as
percentage of predicted (FEV1% pred.). The primary outcome
measurement was the change in weight, either expressed as
absolute weight in kilogramme, weight-for-age z-score, weight
percentile, percentage weight-for-age, percentage of ideal-body-
weight, percentage of weight-for-height, absolute body-mass-
index (BMI) in kg/m2, percentage BMI or BMI z-score. The
secondary outcome measurement was the change in caloric
intake per day and/or forced expiratory volume in 1 s expressed
as % of predicted (FEV1% pred.), if described.3. Results
Nutritional interventions were subdivided into behavioural
intervention (n=6) [11–16], oral supplementation (n=4)
[17–20] and enteral tube feeding (n=7) [21–27]. The treatment
length of the behavioural interventions ranged from 7 weeks
[13–15] to one year [11] and the follow-up period from 1 year
[11,12,16] to 2 years [13–15]. In two oral supplementation
Table 1
Characteristics of behavioural studies.
First author, country, year
of study, study design
Type of intervention Context of
intervention
Sample characteristics Results growth parameters Caloric intake FEV1% predicted
Watson, UK, 2008 [16]
Randomised controlled trial
(34 (I) vs. 34 (C) patients)
Behavioural home-based
nutritional education
programme vs.
standard care
Patients were treated
Treatment
length: 10 weeks
Follow-up: 1 y
outpatient
N=68
Male=40
Mean age (y):
I: 25.2/C: 23.8
Nutritional status:
BMI: I: 21.0/C: 21.6
During follow-up 4 patients
died, 12 defaulted from
follow-up, 3 withdrawn
from study and 1 moved.
Baseline: weight (kg):
I: 59.1±9.7/C: 59.4±10.0//
BMI: I: 21.0/C: 21.6
After 6 mo: weight (kg):
I (N=28): 59.5±10.0/
C (N=32): 60.2±10.8 (p=0.13)
After 12 mo: weight (kg):
I (N=23): 59.9±9.7/
C (N=25): 60.6±11.2 (p=0.18)//
BMI: I: 21.3/C: 21.1 NS
ND Baseline: I: 52.6±25.3/
C: 59.09±22.3
After 6 mo: I: 54.9±25.1/
C: 59.9±20.8 (p=0.576)
After 12 mo: I: 52.8±24.1/
C: 58.3±21.5 (p=0.621)
Powers, US, 2003 [11]
Randomised controlled trial
(4 (I) vs. 4 (C) patients)
Pilot study
Behavioural+nutritional
counselling vs. nutritional
counselling only
Only parents treated
Treatment length:
1 y
outpatient
N=8
Male=ND
Age: b3 y
Nutritional status:
% weight-for-age: 42
Baseline: % weight-for-age:
I: 42.0±13.9/C: 16.7±18.4//weight
(kg): I: 11.6±1.3/C: 10.1±2.1
Post-treatment: % weight-for-age:
I: 46.2±8.2/C: 21.5±9.0//weight
(kg): I: 14.1±1.9/C: 12.8±2.0 NS
Kcal/day//% RDA
Baseline: I: 1020.6±182.3//
% RDA: 78.5±14.0/
C: 1030.8±146.2//% RDA:
C: 79.0±11.2
Post-treatment: I:
1426.6±284.2//% RDA:
109.7±21.9 (p=0.07)/
C: 1316.2±227.3//% RDA:
101.2±17.5 NS
ND
Powers, US 2005 [12]
Randomised controlled trial
(4 (I) vs. 6 (C) patients)
Afterwards 5 patients from
control group underwent
behavioural+nutritional
intervention to replicate
the effects
Behavioural intervention
combined with nutritional
counselling vs.
standard care
Parents were treated
Treatment
length: 8 weeks
Follow-up: 1 y
outpatient
N=10
Male=6
Age (mo): 22–43
Mean age (mo): 31.5±6.2
Nutritional status:
z-score weight-for-age
−0.19±0.85
Baseline: weight z-score:
I: −0.30±0.7/C: 0.08±1.0
After 12 mo (N=9): weight gain
velocity: I: 2.5±0.96 kg/C: ND
(for child of same age at 50th
percentile for weight normal
is 2 kg/12 mo)
Kcal/day
Baseline: I: 1393.1±118/
C: 1387.3±105
Post-treatment: I: 2235.1±706/
C: 1256.0±215 (p=0.011)/caloric
intake increase: I: 842/C: −131
After 3 mo (N=7): 1990.3±337
(pb0.001)/caloric intake
increase: 672
After 12 mo (N=8):
2068.5±484 (pb0.001)/caloric
intake increase: 750
Second sample control group:
5 patients from control group
crossed over to behavioural
nutritional intervention:
Baseline: 1258.7±240
Post-treatment: 2151.5±301
(p=0.03)
ND
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First author, country, year
of study, study design
Type of intervention Context of
intervention
Sample
characteristics
Results growth parameters Caloric intake FEV1% predicted
Stark, US, 2003 [13]
Randomised controlled trial
(3 (I) vs. 4 (C) patients)
Behavioural intervention
combined with nutritional
education vs. nutritional
education only
Both parents+patients
were treated
Pre-treatment
length: 1 week
Treatment length:
7 weeks
Follow-up: 2 y
outpatient
N=7
Male=ND
Age (y): 6–12
Mean age (y): 10
Nutritional status:
weight-for-age below
40th percentile
Baseline weigh-for-age: 12th
percentile, range 3rd–27th
percentile
Post-treatment: weight gain
(kg): I: 1.48/C: 0.78
After 6 mo: I: 3.45/C: 1.45
After 12 mo: I: 5.23/C: 2.97
After 24 mo: I: 7.57/C: 7.32
Weight percentile: I: 2 of 3
increased, 1 stayed on 4th
percentile/C: 2 of 4 declined,
1 stable, 1 increased.
Kcal/day
Baseline increase:
I: 1829/C: 1806
Post-treatment increase:
I: 1036 (±401)/C: 408 (±410)
After 24 mo: I: mean
946 kcal above baseline
C: mean 313 kcal above
baseline
Baseline: mean 95%
(range 75% to 145%)
Stark, US, 2009 [14]
Randomised controlled trial
(33 (I) vs. 34 (C) patients)
Behavioural intervention
combined with nutritional
education vs. nutritional
education only
Both parents+patients
were treated
Pre-treatment
length: 2 weeks
Treatment length:
7 weeks
Follow-up: 2 y
outpatient
N=67
Male=35
Age (y): 4–12
Mean age (y): 7.64
Nutritional status:
weight for age below
40th percentile
During follow-up 12
measurements were missed,
7 patients were dropped
Baseline weight (kg):
I: 21.79±6.44/C: 22.62±7.45
BMI z-score: I: −0.77±1.12/
C: −0.49±0.71
Post-treatment: weight (kg):
I: 23.26±7.1/C: 23.54±7.78//
Weight changes (kg)
I: 1.47±1.27/C: 0.55±1.16
(p=0.01)
BMI z-score: I: −0.39±1.08/
C: −0.31±0.81//BMI changes:
I: 0.38±0.46/C: 0.20±0.47
(p=0.03)
After 24 mo (compared
to pre-treatment):
Weight (kg): I (N=28):
28.51±9.77/C (N=31):
29.51±10.84
Weight changes (kg):
I: 6.97±3.6/C: 6.45±3.67 NS
BMI z-score: I: −0.56±0.9/
C: −0.71±0.66
BMI changes: I: 0.13±0.81/
C: −0.22±0.5 NS
Kcal/day
Baseline: I: 1793±350/
C: 1826±476
Post-treatment:
I: 2655±553/C: 2315±549
Caloric intake increase:
I: 872±478/
C: 489±314 (pb0.001)
After 24 mo (compared
to pre-treatment):
I (N=26): 2523±620/
C (N=25): 2411±577
Caloric intake increase:
I: 721±522/
C: 533±436 NS
Baseline:
I (N=17): 88±18/
C (N=13): 92±18
After 24 mo:
I (N=18): 87±18/
C (N=15): 87±17 NS
Stark, US, 2011 [15]
Retrospective controlled
cohort study (67 (I) vs.
346 (C) patients)
I is intervention and
control group from
Stark et al. 2009
Behavioural intervention
and/or nutritional education
vs. standard care
Both parents+patients
were treated
Pre-treatment
length: 2 weeks
Treatment length:
7 week
Follow-up: 2 y
outpatient
N=67 (control group
N=346)
Male=35 (186)
Age (y): 4–12
Mean age (y): 7.64
Nutritional status:
weight for age below
40th percentile
Baseline BMI z-score:
I: −0.63±0.94/C: −0.47±0.85
After 24 mo post-treatment:
BMI z-score: I: −0.05±0.68/
C: −0.21±0.67
Decline in BMI z-score
significantly less in I group
(pb0.0001)
ND Baseline: I (N=36):
89.95±17.79/
C (N=173): 87.71±20.16
After 24 mo
post-treatment:
I: 88.74/C: 84.45
I: decrease 1.21/C:
decrease 3.25
NS
I=intervention group C=control group RDA=recommended daily allowances P-values from original studies
added when available
ND=not described NS=not significant
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Table 2
Characteristics of oral supplementation studies.
First author, country, year
of study, study design
Type of intervention Context of
intervention
Sample
characteristics
Results
Growth parameters
Caloric intake FEV1% predicted
Skypala, UK, 1998 [19]
Single group
Controlled trial
(26 patients)
Oral supplement: flavoured
powder which has to be
constructed with full-fatty
milk (2 kcal/ml)
Aim of increasing energy
intake by 20% of the
patients' pre-trail
energy intake
Treatment length:
pre-treatment:
4 weeks
Treatment:
8 weeks outpatient
N=26
Male=16
Mean age (y):
18.5 (9–34)
Age≤18 y (N=15)
Inclusion criteria:
Ageb16 y: ideal
weight-for-height
below 95% or recently
a weight loss of 5%
of their usual weight
AgeN16 y: BMI
less than 19
Pre-treatment: weight (kg):
43.8 (24.6–59.9)/
weight-for-height
(% of predicted): 90.6
Baseline, after 4 weeks
pre-treatment weight (kg):
43.7 (26–59.6)/
weight-for-height
(% of predicted): 90.7
Week 12 (end of the
intervention) weight (kg):
45.6 (27.7–59.3) (pb0.01)/
weight-for-height
(% of predicted): 94.8
Pre-treatment: 120% RDA
After 12 weeks: 143% RDA
(pb0.01)
ND
Steinkamp, Germany,
2000 [20]
Prospective randomised
controlled trial
(16 patients oral energy
supplement+dietary
counselling (I)
vs. 20 patients
dietary counselling
(C))
Oral supplement:
Energy supplement
(1.0 kcal/ml, 31 En% fat,
16 En% protein)
Aim: optimize energy
intake by closing
gap between calculated
ideal and actual energy
intake with supplement.
Treatment length:
3 mo
Follow-up:
3 mo outpatient
N=36
Male=20
Mean age (y):
I: 10.4±4.3
C: 13.3±3.8
Inclusion criteria:
Weight-for-height
below 95% of
reference value
Baseline: weight (kg):
I: 32.2±8.9/C: 27.3±7.6
Weight-for-height
(% of predicted):
I: 82.8±8.6/C: 87.8±8.7
After 3 mo: weight
(kg) I: 33.4±9.6
(pb0.05)/C: 27.5±7.5
Weight-for-height
(% of predicted)
I: 84.8±9.6 (pb0.01)/
C: 85.6±10 (pb0.01)
Baseline (kcal/day):
I: 2189±731
C: 1881±507
After 3 mo:
I: 2733±762
(pb0.01)/C: 1928±468
Baseline: I: 52±22/
C: 54±25
After 3 mo:
I: 51±26/
C: 53±20 NS
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First author, country, year
of study, study design
Type of intervention Context of
intervention
Sample
characteristics
Results
Growth parameters
Caloric intake FEV1% predicted
Kalnins, Canada, 2005 [17]
Randomised
controlled trial
(7 patients oral dietary
supplementation (I)
vs. 6 patients dietary
counselling (C))
Oral supplement:
Energy supplement
(1.5 kcal/ml)
Aim of increasing energy
intake by 20% of predicted
energy needs over a
3 mo period
Treatment length:
3 mo
Follow-up:
3 mo outpatient
N=13
Male=3
Mean age (y)
I: 19.5±11.3
C: 16.4±6.7
Inclusion criteria
Below 90%
of ideal-body-weight
or 5% reduction in %
ideal-body-weight
in 3 mo
Baseline: z-score
weight-for-age:
I: −1.2±0.5/C: −0.8±0.8
% ideal-body-weight:
I: 86±8/C: 83±10
After 3 mo: z-score
weight-for-age:
I: −1.1±0.7/C: −0.7±0.6 NS
% ideal-body-weight:
I: 85±6/C: 84±13 NS
After 6 mo: z-score
weight-for-age:
I: −1.3±0.8/C: −0.6±0.9 NS
% ideal-body-weight:
I: 83±6/C: 83±13 NS
Baseline (kcal/day):
I: 2400±600
C: 2800±1100
After 3 mo:
I: 2700±700
C: 2800±700 NS
Baseline: I: 66±22/
C: 62±25
After 3 mo:
I: 60±26/
C: 63±16 NS
After 6 mo:
I: 62±19/
C: 66±13 NS
Poustie, UK, 2006 [18]
Randomised controlled trial
(50 patients oral
supplementation+dietary
counselling (I) vs. 52 patients
single dietary counselling (C))
Oral supplement: Oral
protein energy supplement
Aim of increasing energy
intake by 20% of the
patients' usual
energy intake
Treatment length:
1 y outpatient
N=102
Male=54
Age (y): 2–15
Inclusion criteria:
BMI between 0.4 and
25th centile, no weight
loss previous 3 mo or
5% weight decrease
within 6 mo
Baseline: BMI centile:
I: 34.27±23.96/
C: 31.52±25.36
Weight centile:
I: 25.07±20.37/
C: 24.69±22.79
Differences after
12 mo: BMI centile:
I: 0.67±18.2/
C: −2.32±9.63 NS
Weight centile:
I: 0.83±10.96/
C: −1.0±7.14 NS
Baseline % RDA:
I: 118.43±28.71
C: 116.24±29.59
Differences after 12 mo:
I: 24.48±22.87
C: 6.63±25.21
(p=0.01)
Baseline:
I: 81.34±16.16/
C: 73.67±18.58
Differences after
12 mo:
I: −3.41±13.5/
C: −1.50±14.89
NS
I= intervention group C=control group RDA=recommended daily allowances P-values from original
studies added when available
ND=not defined NS=not significant
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Table 3
Characteristics of enteral tube feeding studies.
First author, country,
year study, study design
Type of intervention Context of intervention Sample characteristics and
inclusion for enteral tube feeding
Results growth parameters Caloric intake FEV1% predicted
Bradley, US,
2012 [22]
Retrospective
controlled
cohort study
(20 patients (I)
vs. 20 (C))
Overnight feeding,
providing 50% of
RDA
Follow-up: 1 y
(simultaneous with
start enteral tube feeding)
Home-based Patients
enrolled in a 5 y span
N=40
Male: I: 8/C: 8
Mean age (y):
I: 9.0±4.4/C: 9.1±4.7
Nutritional status baseline:
BMI below 50th percentile
Baseline: z-score weight-for-age:
I: −1.40±0.55/C: −1.06±0.74 (p=0.07)
z-score BMI: I: −1.19±0.6/
C: 1.10±0.5 (p=0.1)
After 6 mo: z-score weight-for-age:
I: −0.73±0.79/C: −1.01±0.76 (pb0.001)
z-score BMI: I: −0.29±0.84/
C: −1.02±0.67 (pb0.001)
After 12 mo: z-score weight-for-age:
I: −0.76±0.73/C: −0.86±0.70 (p=0.01)
z-score BMI: I: −0.41±0.76/
C: −0.71±0.51 (p=0.07)
ND Baseline: I (N=14):
76.0±19.5/
C (N=13): 75.7±19.0
(p=0.90)
After 6 mo:
I: 74.7±22.0/
C: 78.9±24.0 (p=0.46)
After 12 mo:
I: 74.4±21.4/
C: 82.3±22.9 (p=0.17)
Williams, UK,
1999 [27]
Single group
Pre-test–post-test
(53 patients)
Patients acted as
their own controls
Overnight feeding,
providing 40–60%
of RDA
Follow-up: 1 y
(simultaneous
with start enteral
tube feeding)
Home-based patients
enrolled in a 6 y span
N=53 Male=14
Mean age (y):
22.0±0.8
≤18 y (N=10; 4 boys): mean age (y):
14.7±0.7
N18 y (N=43; 10 male): mean age (y):
23.7±0.8
Nutritional status: BMIb17
Baseline weight z-score: ND
During follow-up
16 patients died
Adults: baseline: weight (kg)
37.4±0.8/z-score BMI: 14.9±0.4
After 6 mo: weight (kg) (N=37):
42.1±1.1 (p=0.0001)/BMI (N=25):
17.7±0.5 (p=0.0001)
After 12 mo: weight (kg) (N=22)
44.2±1.3 (p=0.0001)/BMI (N=21):
17.7±0.4 (p=0.0001)
Children: baseline: weight (kg)
(N=10) 31.9±2.7
After 6 mo: weight (kg) (N=9):
35.3±3.3 (pb0.02)
After 12 mo: weight (kg) (N=6)
35.1±4.7 (pb0.02)
ND Baseline: 21 (13–35)
After 6 mo: 20 (13–35)
After 12 mo: 22
(10–40) NS
Truby, Australia,
2009 [25]
Single group
Pre-test–post-test
(14 patients)
Patients acted as
their own controls
Overnight feeding
5–7 days/week,
providing 1/3–1/2
of estimated energy
requirements
Follow-up: 2 y
(simultaneous
with start enteral
tube feeding)
Home-based
Patients enrolled
in a 6 y span
N=14
M=7
Age (y): 0.42–13
Mean age (y): 6.63
Baseline: z-score weight-for-age:
−1.20±0.82/BMI (N=9): −1.13±0.61
After 1 y: z-score weight-for-age:
−1.05±0.73 (p=0.475)/BMI (N=9):
−0.56±0.62 (p=0.01)
After 2 y: z-score weight-for-age:
−1.15±0.92 (p=0.546)/BMI
(N=9): −0.98±1.01 (p=0.108)
ND Baseline: (N=7)
71.02±13.53
After 1 y: 67.26±17.54
(p=0.405)
After 2 y: 66.28±14.73
(p=0.498)
Van Biervliet, Belgium
2004 [26]
Single group
Pre-test–post-test
(11 patients)
Patients acted as their
own controls
Overnight feeding,
providing 40%
of RDA
Follow-up: 2 y
(simultaneous
with start enteral
tube feeding)
Home-based
N=11
Male=3
Age (y): 0.6–14.8
Median age (y): 9.4
Nutritional status:
weight-for-heightb85%
or z-score heightb−2
Baseline % weight-for-height: median:
81 (67–90)/z-score BMI: −2.34
(−2.95–−1.29)
After 3 mo (N=7): % weight-for-height:
N90/z-score BMI −1.11 (−2.18–1.35)
After 6 mo (N=7): % weight-for-height:
91 (75–119) (p≤0.05)/z-score BMI:
−1.32 (−2.04–0.63) (p≤0.05)
Kcal/day before
insertion
gastrostomy
940–2011
After start enteral
tube feeding:
1027–2666 RDA by
enteral tube feeding:
40% (14%–90%)
NS
Efrati, Israel, 2006 [23]
Single group
Pre-test–post-test
(21 patients)
Overnight feeding,
providing 40–60%
of RDA
Follow-up: 2 y (simultaneous
with start enteral tube feeding)
Home-based Patients enrolled
in a 9 y span
N=21
Male=10
Age: 8 mo–20 y
Mean age: ND
Baseline: z-score weight-for-age:
−3.1±1.4/z-score BMI: −2.1±1.3/%
ideal-body-weight: 84.6±8.5
After 6–12 mo (N=21): z-score
ND Baseline: (N=16)
44.2±13.9 (25–77)
After 6–12 mo:
(N=15): 41±13.3
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year study, study design
Type of intervention Context of
intervention
Sample characteristics and
inclusion for enteral tube
feeding
Results growth parameters Caloric intake FEV1% predicted
Patients acted as their
own controls
Nutritional status: %
weight-for-height below
85 or weight loss for more
than three consecutive mo
During follow-up 1 patient died
weight-for-age: −2.5±1.5
(p=0.013)/z-score
BMI: −1.2±1.2 (p=0.001)/
% ideal-body-weight: 95.1±12.9 ND
After 18–24 mo (N=14): z-score
weight-for-age −2.6±1.5
(p=0.026)/z-score
BMI: −1.27±1.11 (p=0.006)/
% ideal-body-weight: 96.5±11.1 (p=0.003)
(25–67) (p=0.05)
After 18–24 mo:
(N=14) 41.4±16.1
(16–65) trend toward
improvement
Rosenfeld, US, 1999 [24]
Single group
Pre-test–post-test
(21 patients)
Patients acted as their
own controls
Overnight feeding,
providing 1/4–1/2
of RDA
Follow-up: 4 y (simultaneous
with start enteral tube feeding)
Home-based
Patients enrolled in a 13 y span
N=21
Male=7
Age (y): 1.1–20.8
Median age (y): 7.4
Weight less than 90% of
ideal, linear stunting or failure
to progress along baseline
weight percentile for 3 to 6 mo
Baseline (N=21): median % ideal-
body-weight: 89 (72–95)/median
weight: 2nd percentile (0.2–36)
After 6–18 mo (N=18): median %
ideal-body-weight: 90 (85–99)
(p≤0.002)/median weight: 12th
percentile (1–28) (p≤0.002)
After 18–30 mo (N=18): median %
ideal-body-weight: 93 (86–98)
(p≤0.002)/median weight: 12th percentile
(1–29) (p≤0.002) After 30–48 mo (N=14):
median % ideal-body-weight: 98 (94–107)
(p=0.002)/median weight: 19th percentile
(1–31) (p=0.002)
ND ND
Best, US, 2011 [28]
Single group
Pre-test–post-test
(46 patients)
Patients acted as
their own controls
ND Follow-up: 4 y (2 y
pre-treatment–4 y
post-treatment)
Home-based
Patients enrolled in a 20 y span
N=46
Male=28
Age (y): 5–50
Age at gastrostomy tube placement
b18 y: (N=33; 20 boys) mean age
(y): 11 (5–15)
≥18 y: (N=13; 8 men)
mean age (y): 26 (18–50)
Nutritional status baseline:
Overall: BMI percentile: 13.3
b18 y: ND
≥18 y: BMI absolute: 18.2
During follow-up 4 patients
died, 8 underwent lung
transplantation
BMI percentile 2 y pre-treatment–1 y
post-treatment
Overall (N=46): from 13.3 to 19.1, median
% BMI change: +6.3% (p=0.0007)
Men (N=8): median % BMI change:
+4.6% (7 patients improved)
Women (N=5): median % BMI change:
−8.3% (1 patient improved)
Boys (N=20): median % BMI change:
+8.3% (16 patients improved)
Girls (N=13): median % BMI change:
+7.1% (12 patients improved)
BMI percentile 2 y pre-treatment–2 y
post-treatment
Overall (N=39): from 14.6 to 36.8, median
% BMI change: +13.3% (pb0.0001)
Men (N=5): median % BMI change:
+9.0% (5 patients improved)
Women (N=3): median % BMI change:
−5.0% (1 patient improved)
Boys (N=19): median % BMI change:
+14.0% (15 patients improved)
Girls (N=12): median % BMI change:
+16.0% (10 patients improved)
BMI percentile 2 y pre-treatment–4 y
post-treatment
Overall (N=29): from 14.5 to 26.0, median
ND Slope before start enteral
tube feeding per year
Men: −5.91 (p=0.0019)
Woman: – 8.59 y
(p=0.0001)
Boys: −1.13 (p=0.3453)
Girls: −4.32 (p=0.0055)
Slope change after
start enteral tube
feeding per year
Men: 5.01 (p=0.0159)
Woman: 4.48 (p=0.0712)
Boys: 1.49 (p=0.2297)
Girls: 4.02 (p=0.0107)
(continued on next page)
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Table 3 (continued)
First author, country,
year study, study design
Type of intervention Context of intervention Sample characteristics and
inclusion for enteral tube feeding
Results growth parameters Caloric intake FEV1% predicted
% BMI change: +8.9% (p=0.0067)
Men (N=3): median % BMI change:
+13.5% (3 patients improved)
Women (N=1): median % BMI change:
−20.7% (0 patients improved)
Boys (N=15): median % BMI change:
+6.8% (8 patients improved)
Girls (N=10): median % BMI change:
+14.1% (8 patients improved)
I= intervention group C=control group RDA=recommended daily allowances P-values from original studies added
when available
ND=not defined NS=not significant
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111J.W. Woestenenk et al. / Journal of Cystic Fibrosis 12 (2013) 102–115studies, the treatment length varied from 8 weeks [19] to 1 year
[18]. In both, the follow-up started simultaneous with the
introduction of the oral supplement and the duration was equal
to the treatment length. The two other oral supplementation
studies both had a treatment and follow-up period of 3 months
[17,20] respectively. The follow-up of the enteral tube feeding
interventions started simultaneous with the start of the tube
feeding and lasted up to 4 years [24,28]. The control groups were
CF patients who did not have the intervention [11–18,20,22], or
subjects who served as their own control [12,19,23–28]. Data
are summarized in Tables 1, 2 and 3, respectively.
Sample characteristics of the nutritional intervention studies
tended to be heterogeneous. The sample sizes varied from 7
[13] to 102 subjects [18], and age ranged from 5 months [25] to
50 years [28]. Furthermore, the baseline nutritional status
differed from well-nourished adult patients (BMI 21.0) [16]
to severely malnourished paediatric patients (mean z-score
weight-for-age −3.05) [23].
The primary outcome was weight gain. Changes in caloric
intake per day and/or the FEV1% pred. were described in
9 [11–14,17–20,26] and 11 studies respectively [14–
18,20,22,23,25,27,28].3.1. Behavioural intervention studies
3.1.1. Design
Six behavioural intervention studies were included which
differed in design [11–16]. The ‘home-based’ nutritional edu-
cation programme of Watson et al. focusing on well-nourished
adults, was unique [16]. In this study, the intervention group
received 10 learning modules which were designed to take
30 min per week and were to be completed at home. They also
received a newsletter every 2 weeks and 3 workshops at the
clinic were organised as well: before, halfway and at the end
of the home-based programme. The intervention group was
rewarded for making changes as well as for strengthening their
behavioural changes. The control group received standard care.
The follow-up measurements of anthropometry and pulmonary
function took place 6 and 12 months after the end of the
intervention. The other five studies focused on behavioural
modification in children who in general had z-scores for weight
indexes below 0 and above −1. The first behavioural and
nutritional intervention in the study of Powers et al. was
conducted over a 1 year period in which families received
8 one-hour sessions which included nutritional counselling and
behavioural management training [11]. This relatively small
study (8 patients) served as pilot for a subsequent study con-
ducted in 2005 [12]. In the latter, parents were trained in
effective child behavioural management skills, combined with
individualized nutritional counselling that targeted increasing
energy intake in one specific meal each week. The study was
performed over an 8 week period and included a baseline study
visit and 6 intervention sessions held in week 3 to 8. After these
8 weeks, the control group was able to cross over to the
same intervention as given to the first intervention group to
replicate the effect of the intervention. The one-year follow-upassessments for anthropometric data took place every 3 months
and a diet diary was completed at 3 and 12 months follow-up.
In all 3 studies of Stark et al., both the parents and children
in the intervention and control group were provided with the
same nutritional information and caloric goals during 7 weekly
sessions [13–15]. In the first 2 studies performed by Stark et al.
[13,14], parents of the intervention group were instructed in
behavioural management to motivate their child to eat, while
the children received behavioural training in meeting weekly
caloric goals as well as a behavioural reward programme. In the
2011 study [15] the intervention group consisted of the inter-
vention group and the control group of the previous study of
Stark et al. conducted in 2009 [14]. This implied that the
intervention group received either behavioural management
instructions and nutritional counselling or nutritional counselling
only. Pooling of both groups from the 2009 study into the
2011 intervention group was considered correct as no significant
differences at 2 year follow-up were found between these 2
groups. Growth in the combined intervention group was com-
pared with growth of CF patients receiving standard care during
the same time period. This control group was randomly drawn
from the US-CF registry. In all 3 studies the follow-up
assessments for anthropometric, caloric intake and pulmonary
function data took place at 6, 12 and 24 months and in both the
2009 and 2011 studies also at 3 and 18 month after the end of
treatment.
3.1.2. Nutritional status
Watson et al. and Powers et al. 2003 described no effects of
the behavioural intervention on nutritional status [11,16]. The
intervention group in the study of Powers et al. 2005 had
normal weight velocities [12] but no information was available
on the control group because this group crossed over to the
combined intervention group. Both the 2003 and 2009 studies
of Stark et al. reported that the intervention group had gained
more weight in comparison to the control group at initial
evaluation points [13,14]. However after 2 years follow-up the
intervention group had not gained more weight than the control
group. The 2011 study of Stark et al. demonstrated a significant
less decline in BMI z-score between the combined intervention
group and the control group that was randomly selected from
the US-CF registry [15].
3.1.3. Caloric intake
Four behavioural studies described the caloric intake per day
[11–15]. In the pilot study of Powers et al. 2003, no significant
differences were found in the caloric intake between the
intervention group (behavioural intervention combined with
nutritional counselling) and the control group (nutritional
counselling only) [11]. Nonetheless in 2005 the same group
found a significant improvement in caloric intake after
3 months as well as after 12 months in a group that received
behavioural and nutritional counselling [12]. Similar results
were found in the group who crossed over from the control
group to the intervention group. In 2 studies of Stark et al.,
children receiving behavioural intervention combined with
nutritional counselling increased their daily caloric intake more
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[13,14], although this effect did not persist after a 2 year
follow-up [14].
3.1.4. Pulmonary function
Three behavioural studies described pulmonary function
before and after the intervention [14–16]. No significant
differences in pulmonary function were found before and after
intervention, although in one study the decline in pulmonary
function in the intervention group seemed to be slower than in
the control group, although not significantly so [15].
3.2. Oral supplementation studies
3.2.1. Design
Included were 4 studies which investigated the effect of
adding high energy supplements to the usual oral intake in
patients with weight indexes z-scores below 0 and above −2
[17–20] of which the children in the study of Poustie et al. [18]
and Skypala et al. [19] had weight indexes above z-score −1.
The supplement in each study was different, but aimed at either
increasing energy intake by 20% or having an intake that was at
least equivalent to the calculated energy requirements. In the
study of Skypala et al. the children and adults acted as their
own controls [19]. In the 4 weeks pre-treatment period they
were monitored on their usual diet including oral supplements
and overnight enteral tube feeds. In the 8 weeks intervention
period, the overnight enteral tube feeds where continued while
the oral supplements were replaced by the intervention
supplement which was prescribed in a dose equivalent to a
minimum of 20% of the patients' pre-trial energy intake. The
intervention supplement was a flavoured powder which was not
fortified which vitamins and minerals and, when reconstituted
with 240 ml of full-fat milk, contained 2 kcal/ml. The anthro-
pometric assessments took place during the intervention at
week 0, 4 and 12. No further follow-up measurements were
performed.
The children enrolled in the study of Steinkamp et al. were
randomly allocated to a control group or to an intervention
group [20]. During 3 months both the control group and the
intervention group received dietary counselling while the
intervention group additionally received an oral supplement
with 1.0 kcal/ml with 31% of energy from fat (half of which
was linoleic acid), and 16% of energy from protein. Anthro-
pometric, caloric and pulmonary function data were obtained
after 3 months follow-up. In the relative small study (13
patients) of Kalnins et al., a ready-to-use supplement with
1.5 kcal/ml, consisting of 30% of energy from fat and 20% of
energy from protein was prescribed to children and adults,
during a 3 months period with the aim to increase energy-
intake by 20% of predicted energy needs [17]. The control
group received dietary counselling in which it was advised
to increase the energy intake by eating high calorie foods.
Anthropometry and pulmonary function were evaluated at
the end of the intervention and after 3 months follow-up, the
change in caloric intake only at the conclusion. In the one-year
study of Poustie et al., children were randomised into a groupwho had dietary counselling and oral supplements and into a
group who had dietary counselling only [18]. The nutritional
facts of the prescribed oral supplements were heterogeneous
but all aimed at increasing the energy intake by 20%. The
assessments for anthropometric, caloric intake and pulmonary
function data took place during the intervention at 3, 6 and
12 months.
3.2.2. Nutritional status
Two studies described a significant weight gain after inter-
vention, either when comparing to the pre-intervention weight
in the same group [19] or when compared to the weight of a
control group without the intervention [20]. The other 2 studies
did not find an effect on weight variables at the end of the
intervention period [17,18].
3.2.3. Caloric intake
All 4 studies described the caloric intake. Apart from the
study by Kalnins et al. [17] all showed a significant increase in
caloric intake at the end of the intervention period [18–20].
3.2.4. Pulmonary function
Three studies described the pulmonary function and in none
of these studies significant differences in FEV1% pred. were
found between intervention and control groups, neither before
nor after the intervention [17,18,20].
3.3. Enteral tube feeding studies
3.3.1. Design
Seven studies on enteral tube feeding were included [22–28].
Four studies enrolled patients with weight indexes z-scores
below −1 [22,24,25,28], and 3 studies included malnourished
patients (weight indexes z-scores below −2) [23,26,27]. Each
investigated the effect of overnight tube feeding given by
gastrostomy, thus providing 25%–60% of the recommended
daily advised (RDA) caloric intake. The study of Bradley et al.
[22] was unique as it was a pair-matched controlled study, while
all other studies did not include a control group, but evaluated
the effect of the intervention by comparing baseline weight
indexes with the same variable after enteral tube feeding was
implemented for some time. Bradley et al. supplemented
18 children, who were enrolled over a 5-year span, with a
whole-protein formula, 1 with a partially hydrolysed formula
and 1 with an elemental formula. The anthropometric and pul-
monary assessments took place at 6 and 12 months. Williams
et al. enrolled both children and adults and prescribed a
concentrated modular elemental feed combined with Polycose
(up to 2.6 kcal/ml) to pancreatic insufficient patients and to
sufficient patients a whole protein feeding (1.5 kcal/ml) [27].
For both groups the enteral tube feeding provided 40–60% of
the RDA and at month 6 and 12 anthropometry and pulmonary
function data were obtained. In the study of Truby et al.,
children were provided with enteral tube feeding containing 1 or
1.5 kcal/ml. Anthropometric and pulmonary function data were
assessed 1 and 2 years after the start of the enteral tube feeding
[25]. Both studies enrolled patients over a period of 6 years. The
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RDA by providing a high energy (1.5 kcal/ml) polymeric tube
feed [26]. They studied data of children from 2 years before
and after the gastrostomy insertion and evaluation of anthropo-
metric data took place after 3 and 6 months of the gastrostomy
insertion. The time span of enrolment was not described. Efrati
et al., Rosenfeld et al. and Best et al. investigated the effect
of enteral tube feeding of both children and adults included
over a period of respectively 9-years, 13-years and 20-years
[23,24,28]. The follow-up assessments for anthropometric data
in the study of Efrati et al. took place after 6–12 months and
18–24 months while the other 2 studies assessed both anthro-
pometric and pulmonary function data in various time periods
during the 4 years of follow-up [24,28]. These last 3 studies did
not mention the type of the enteral tube feeding prescribed.
3.3.2. Nutritional status
In the only study that included a control group, the inter-
vention group significantly improved in z-score weight and
z-score BMI after 6 and 12 months of enteral tube feeding [22].
Apart from the study by Williams et al. [27] who reported
both absolute weight gain and z-score BMI, the other studies
reported either percentiles, percentages or z-scores for weight
variables. Also those studies that included both children and
adults [23,24,27,28] reported separate data for adults and
children.
In 5 studies, a significant improvement in the weight
variables was found after the start of enteral tube feeding,
with follow-up periods lasting from 1 year [26,27] to 2 years
[23] to 4 years [24,28]. Although, Truby et al. described a
significant improvement in z-score weight after 1 year of
enteral tube feeding, in the second year the weight gains were
less evident with no significant change in the weight indexes
[25].
3.3.3. Caloric intake
The caloric intake was only reported in the study of Van
Biervliet et al. [26]. In this study, patients improved their
caloric intake with approximately 40% of the recommended
daily intake after the start of the enteral tube feeding.
3.3.4. Pulmonary function
Five studies described the pulmonary function [22,23,
25,27,28]. Stabilisation in pulmonary function in the inter-
vention group after 6 and 12 months providing enteral
tube feeding was found in the studies of Bradley et al. [27]
and Williams et al. [22]. Two studies demonstrated a gradual
decline in pulmonary function, respectively from 71% FEV1
pred. at baseline to 67% after 1 year and to 66% after 2 years
of gastrostomy feeding [25], and from 44% at baseline to 41%
FEV1 pred. after 1 year of gastrostomy feeding, and stabilising
at 41% FEV1 pred. after 2 years [23]. Best et al. found a
significant reduction in the rate of pulmonary decline after the
start of enteral tube feeding in girls, as well as in adult men (all
pb0.05), while women showed a trend toward improvement
[28]. For boys, no significant improvement in the decline of
pulmonary function was found, but it should be noted that theinitial rate of pulmonary function decline in boys was already
low (−1.13%/y) in contrast to the initial rates of decline in
other subgroups (from −4.32%/y to −8.59%/y), so an
improvement might be more difficult to detect.
4. Discussion
This review demonstrates that in 1 out of the 6 behavioural
studies a significant weight gain was found and in another
study an increased caloric intake, although this was not
reflected in weight gain. Oral supplementation proved to be
successful in improving weight variables in 2 out of 4 studies,
and in caloric intake in 3 out of 4 studies No positive effects
of behavioural interventions or oral supplementation on pul-
monary function were described. In all studies, enteral tube
feeding via gastrostomy results in significant weight gain and
also slows a further decline in pulmonary function in patients
with CF.
The earlier meta-analyses by Jelalian et al. [8] in 1997,
included 4 behavioural, 6 oral supplementation, 5 enteral tube
feeding and 3 parental nutrition studies reported that all
interventions were effective in inducing weight gain, with
parenteral nutrition having the largest effect, then enteral
nutrition, then oral supplementation while behavioural in-
terventions had the smallest effect. However the difference in
weight gain between the four types of intervention was not
significant. As opposed to this earlier study, the current study
did not find an improvement in weight for each nutritional
intervention. This difference might be partly due to the small
sample size for the studies analysed by Jelalian, which ranged
from 3 to 15 patients, with a total number of 17 patients
analysed for behavioural intervention, 56 for oral supplemen-
tation and 52 for enteral nutrition, which is less than the largest
single centre study in each of these three groups in the current
review. Moreover, the results of the meta-analysis represented
only the effectiveness of half of the studies conducted because
other studies were lacking data for an effect size calculation.
The limited number of available studies could significantly
affect the estimated effectiveness and possible studies which
were not effective in improving weight gain were excluded.
Given the differences in sample size numbers and limited data
analysed, it is conceivable that some of the findings by Jelalian
et al. could not be replicated in the current review. In addition
the nutritional status for the CF population at large has been
considerably improved since the meta-analysis by Jelalian was
done, with, for example, a 7.8% gain in median BMI percentile
between 2000 and 2010 [9]. In the current population of CF
patients, with a better nutritional status, the effect of inter-
ventions which induce only marginal weight gain would be
harder to detect, especially conducted in patients who are only
just below z-score 0 with respect to weight variables, such as in
the behavioural intervention studies now analysed.
The generalizability of the results of studies analysed in this
review was limited due to the heterogeneity of the intervention
groups, with respect to age, nutritional status, caloric intake,
pulmonary function and the duration of the studies. Firstly, the
sample size varied widely, from 7 [13] to 102 patients [18],
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[11–15], 1 oral supplementation [17] and 2 enteral tube feeding
interventions [25,26]) included less than 15 patients. Secondly,
the patients included in the reviewed studies had a large age
range, varying from 5 months [25] to 50 years [28], with
nutritional intervention studies in children being overrepre-
sented as respectively 10 (5 behavioural [11–15], 2 oral
supplemental [18,20] and 3 enteral tube feeding interventions
[22,25,26]) and 6 (2 oral supplemental [17,19] and 4 tube
feeding interventions [23,24,27,28]) out of 17 studies analysed
enrolled children or both children and adults while 1 study
(behavioural intervention [16]) included only adults. Although
none of the studies demonstrated that specific age groups
benefit from a particular intervention, the impact of age on
treatment efficacy is not clear at present. Thirdly, the included
patients varied in baseline weight from well-nourished [16]
to malnourished [23,26,27]. Behavioural interventions were
mainly conducted in patients with weight indexes above
z-scores −1 [11,12,14–16] while enteral tube feeding in-
terventions were only done in patients with weight indexes
below z-scores −1. Moreover malnourished patients (weight
indexes below z-scores −2) received only enteral tube feeding
and no other type of intervention [23,26,27]. Therefore the
effectiveness of behavioural interventions and/or oral supple-
mentation in malnourished patients cannot be reviewed.
Fourthly, respectively 8 [15,16,22–25,27,28] and 6 studies
[11–13,19,24,26] lacked data on caloric intake or pulmonary
function so the effect of the interventions on these variables
could not be assessed consistently. Lastly, the study duration
varied from 7 weeks in behavioural interventions [13–15] to
4 years in enteral tube feeding [24,28] and the follow-up from
8 weeks in oral supplementation [19] to 4 years in enteral tube
feeding studies [24,28].
It is also important to note that a single research group
from the Cincinnati Children's Hospital Medical Centre, was
responsible for 5 out of 6 behavioural intervention studies
[11–15]; no independent confirmation of their results has been
published so far. So the generalizability of their results is
unclear at present. In addition the intervention group enrolled in
the study of Stark et al. 2011 [15], was the study group and
control group from the study of Stark et al. 2009 [14], which
approach was considered justified as no differences between
both groups were found at final follow-up. The results of this
combined intervention group were subsequently compared to a
nationwide reference group randomly drawn from the US-CF
registry. This registry stored patient information from all
centres, including non-specialized centres. However patients
from centres with a focus on CF care often show better growth
results than nationwide cohorts [3,29], so it is unclear as to
whether the better growth described by Stark et al. for the
intervention group is not – partly – due to this effect.
Despite these limitations, some conclusions seem to emerge
from the studies reviewed. Nutritional intervention seems
especially effective when applied to severely malnourished
patients (weight indexes z-scores below −2); in this patient
group enteral tube feeding, which is usually or most often done
through a gastrostomy in any patient needing this interventionfor a longer period, has proven to be successful, both to
improve nutritional status and to slow decline in pulmonary
function [21,23,25]. The studies included in this systematic
review give less guidance for patients with weight indexes
z-scores below −1 and above −2. In those patients enteral
nutrition is also effective, at least during the first year
[20,22,24,26]. As this intervention is invasive, oral supplemen-
tation might be started initially, as the study of Steinkamp et al.,
conducted in patients with weight indexes below −1 and above
−2, demonstrated both a significant weight improvement and
an increase in caloric intake [20]. With respect to behavioural
intervention in this patient group only the 2003 study by Stark
et al. showed a trend in weight gain during the first year, but not
at the end of the follow-up [13]. So it is not clear at present as to
whether CF patients with z-scores for weight indexes below −1
and above −2 benefit from this intervention. In patients with
weight indexes z-scores below 0 and above −1 as enrolled in
the studies of Skypala et al. [19] and Poustie et al. [18], the
addition of oral supplementation seems successful in improving
weight [19] and/or increasing the caloric intake [18]. Only one
behavioural intervention conducted in this patient group (Stark
et al. 2009 [14]) showed significant weight gain, but only at the
end of the intervention, and not at final follow-up; in addition,
one behavioural study (Powers et al. 2005 [12]) described an
increased caloric intake. So, to date it is unclear as to whether
this intervention should be routinely implemented in CF
patients with a less than normal weight.
Nowadays, the nutritional support is an integral part of
multidisciplinary care of patients with CF, supported by
international clinical guidelines for nutritional management
[6,7]. These guidelines provide recommendations for identify-
ing patients at-risk for malnutrition as well as for those with
actual malnutrition. In these groups early intervention is
extremely important to prevent negative long-term effects,
although it is not always clear at present which type of
intervention is most appropriate. Future studies, which should
include a control group receiving current best treatment [6,7]
might determine more precisely which patient group may
benefit most from behavioural interventions and/or oral
supplements. The behavioural and oral supplementation in-
terventions described in this systematic review also were
relatively short (maximally 1 year, mostly 3 months or less).
As the aim for CF patients is to obtain a — near – normal
nutritional status for their entire life time, future studies should
have a longer intervention and follow-up, so it will become
clear whether observed short term effects will persist over a
longer period. Finally, as the ultimate goal for CF patients is a
slower decline of pulmonary function, studies investigating
nutritional interventions should include pulmonary function
variables. Ideally these goals would be attained in prospective
randomised controlled trials designed to assess the effect of a
behavioural or oral supplementation intervention in CF patients
with a weight for age z-score between 0 and −2, as for these
interventions the effect is not sufficiently clear yet. Study
duration should be at least one year, as is the follow-up, and
outcome variables should include weight variables as well as
FEV1% pred.
115J.W. Woestenenk et al. / Journal of Cystic Fibrosis 12 (2013) 102–1155. Conclusion
The studies included in this systematic review give less
guidance for the role of behavioural intervention and oral
supplements. However it can be concluded that enteral tube
feeding is effective to improve the nutritional status, especially
in malnourished patients, and to slow further pulmonary
function decline in patients with Cystic Fibrosis.
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